(Q34825735)

4 August 2017

1 reference

title

Peroxisome proliferator-activated receptor-gamma in macrophage lipid homeostasis (English)

1 reference

4 August 2017

1 reference

2

Ronald M Evans

0 references

author name string

Chih-Hao Lee

series ordinal

1

1 reference

4 August 2017

1 October 2002

1 reference

Trends in Endocrinology and Metabolism

4 August 2017

1 reference

4 August 2017

13

1 reference

4 August 2017

8

1 reference

4 August 2017

331-335

1 reference

Nuclear receptors and lipid physiology: opening the X-files

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

Peroxisome proliferator-activated receptors: nuclear control of metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

Peroxisome proliferator-activated receptors: from genes to physiology

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

Positive regulation of the peroxisomal beta-oxidation pathway by fatty acids through activation of peroxisome proliferator-activated receptors (PPAR)

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

PPAR gamma is required for placental, cardiac, and adipose tissue development

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

Regulation of lineage commitment during lymphocyte development

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

Transcription factors that regulate growth and differentiation of myeloid cells

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

Transcriptional regulation in acute promyelocytic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

The role of PPAR-gamma in macrophage differentiation and cholesterol uptake.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

1 reference

7 January 2021

Atherosclerosis. the road ahead

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

Peroxisome proliferator-activated receptors in endothelial cell biology

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

Activation of peroxisome proliferator-activated receptor gamma does not inhibit IL-6 or TNF-alpha responses of macrophages to lipopolysaccharide in vitro or in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

Inhibition of IkappaB kinase and IkappaB phosphorylation by 15-deoxy-Delta(12,14)-prostaglandin J(2) in activated murine macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

The multiple roles of macrophage scavenger receptors (MSR) in vivo: resistance to atherosclerosis and susceptibility to infection in MSR knockout mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

Structure, function and regulation of the ABC1 gene product

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

Mouse models of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDL.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

Autoregulation of the human liver X receptor alpha promoter

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900668-9

7 January 2021

10.1016/S1043-2760(02)00668-9

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12217489